Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Humira exclusivity expires in 2023: Will biosimilar boom benefit patients or industry? Rob Volansky; Monica Stonehill
-
- Digesting 2022 and looking forward to 2023 in IBD therapeutics Edward V. Loftus Jr., MD
- AGA releases 10 best practice statements for management of refractory celiac disease Monica Stonehill
- Early feeding safe after percutaneous endoscopic gastrostomy tube placement Gina Brockenbrough, MA
- FDA approves fecal microbiota biotherapeutic for recurrent C. difficile infection
- FDA grants fast track status to LB1148 for quicker return of postoperative bowel function
- GI societies praise CMS for expanding CRC screening, raise concerns for reimbursement cuts Monica Stonehill
- Older patients with IBD at higher risk for treatment failure with vedolizumab Kristen Dowd
- Q&A: Not just a ‘sweet treat,’ dark chocolate packed with benefits for a healthy gut Monica Stonehill; Sunny Jain, MS
-
- Ramping up HCV elimination tactics could save 90,000 lives, $60 billion by 2050 Katrina Altersitz
- VEGA: Guselkumab plus golimumab achieved higher clinical remission rates in UC Kate Burba
- Vibrating capsule safe, well tolerated, easy to use in chronic idiopathic constipation Kristen Dowd
- VIDEO: Physicians should rely on clinical expertise as foundation for social media presence Monica Stonehill; Austin Chiang, MD, MPH